Sort
40,608 grants matching “prostate cancer”
Telomere length and chromosomal instability across various tissue types
$300,000Brandon Lee Pierce · University Of Chicago · U01 · FY2015 · HG
GASTROINTESTINAL MICROBIOTA AND IMMUNOTHERAPY IN ADVANCED PROSTATE CANCER
$300,000The Johns Hopkins University · · FY2018 · Department of the Army
Systemic delivery of chitosan/miRNA nanoparticles to prostate tumors
$299,999Andreas G Bader · Mirna Therapeutics, Inc. · R43 · FY2012 · CA
Novel Single Chain Antibodies against MIF for Prostate Cancer Therapy
$299,999Norman Zhennan Lai · Ibex Biosciences, Llc · R43 · FY2017 · CA
Combinatorial Brain Cancer Therapy through Irreversible Electroporation and Carbon Nanotubes
$299,998Rafael V Davalos · Virginia Polytechnic Institute And State University · · FY2009 · ENG
Quantitative SPECT of Difficult to Image Therapeutic Radionuclides: An Extensible Cloud-Based Framework
$299,995Michael Ghaly · Radiopharmaceutical Imaging And Dosimetry, Llc · R43 · FY2018 · CA
Portable Imaging Device for Prostate Cancer Detection
$299,994Armen Sarvazyan · Artann Laboratories, Inc. · R44 · FY2009 · CA
Elucidating novel epigenetic modifications implicated in multiple myeloma risk disparities
$299,993Brian C-H Chiu · University Of Chicago · R56 · FY2023 · CA
UV-emitting nanoparticles as novel radiation sensitizers targeting hypoxic cells
$299,992Michael R Squillante · Radiation Monitoring Devices, Inc. · R41 · FY2017 · CA
A Phase Ib clinical trial with niclosamide plus abiraterone for Castration Resistant Prostate Cancer (CRPC)
$299,986Chengfei Liu · Pandomedx, Inc. · R43 · FY2016 · CA
Role of Stat3 in modulating tumor microenvironnment and angiogenesis
$299,975Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2006 · CA
IGF::OT::IGF TOPIC 338 PHASE I SBIR DEFINING NORMAL TISSUE AND TUMOR BIOMARKERS OF RADIOSENSTIVITY TO DETECT TREATMENT
$299,957Richard Gatti · Mira Dx, Inc. · N43 · FY2015 · CA
Gender-Affirming Testosterone Therapy on Breast Cancer Risk and Treatment Outcomes
$299,940Yu Jing Jan Heng · Beth Israel Deaconess Medical Center · R56 · FY2023 · CA
A Novel Brachytherapy Agent for GBM
$299,937Thomas C Chen · Applied Integrin Sciences, Inc. · R41 · FY2013 · CA
Smart template for prostate biopsy guidance
$299,927Jesung Park · Physical Sciences, Inc · R44 · FY2018 · CA
Development of Fluorescent Probes for Highlighting Nerves During Image Guided Surgeries
$299,912Michael A Whitney · Alume Biosciences, Inc. · R43 · FY2019 · NS
PCR for carbohydrate cancer biomarkers
$299,904Ian E Burbulis · Vtt/Msi Molecular Sciences Institute · R21 · FY2010 · CA
Prostate carcinogenesis and PKC signaling
$299,903University Of Pennsylvania · R01 · FY2005 · CA
Design of Oncolytic Adenovirus Conjugated with Novel Polymer for Cancer Treatment
$299,900Sung Wan Kim · University Of Utah · R01 · FY2014 · CA
Targeting myristoylation of Src family kinases for inhibition of prostate tumorig
$299,900Houjian Cai · University Of Georgia · R01 · FY2014 · CA
SCH: Active Learning for Medical Applications
$299,899Nikos Papanikolopoulos · University Of Minnesota · R01 · FY2019 · CA
Population Impact of Cancer Control Processes
$299,885Alexander Tsodikov · University Of Michigan At Ann Arbor · U01 · FY2009 · CA
Medical Versus Minimally Invasive Therapy for BPH
$299,874Baylor College Of Medicine · U01 · FY2004 · DK
Large Volume Intratumoral Injection Device for Therapeutic Liver Infusions
$299,842Jim Stice · Twin Star Tds, Llc · R43 · FY2015 · CA
Promoting Healthy Cancer Survivorship in Rural Colorado Primary Health Care Pract
$299,836Linda Overholser · University Of Colorado Denver · R25 · FY2016 · CA